Calcium-channel blockers in systemic hypertension
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference220 articles.
1. A new group of compatible Ca++ antagonists (iproveratril, D600, prenylamine) with highly potent inhibitory effects on excitation-contraction coupling in mammalian myocardium;Fleckenstein;Fluegers Arch,1969
2. Calcium channel blocking agents in the treatment of cardiovascular disorders: II: Hemodynamic effects and clinical applications;Stone;Ann Intern Med,1980
3. Critical value of calcium antagonists in treatment of cardiovascular disorders;Krikler;J Am Coll Cardiol,1983
4. Nifedipine, a new antihyperteusice with rapid action;Guazzi;Clin Pharmacol Ther,1977
5. Calcium entry blocking drugs: Mechanisms of action, experimental studies and clinical use;McCall;Curr Proh Cardiol,1985
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Verapamil Revisited;Heart Disease;2001-01
2. Mechanisms Offsetting the Beneficial Effects of Antihypertensive Drugs: A Problem Increasingly Considered but Incompletely Understood;Clinical Research and Regulatory Affairs;1998-01
3. Management of Hypertensive Urgencies and Emergencies;The Journal of Clinical Pharmacology;1995-08
4. A New Extended-Release Formulation of Diltiazem HCl for the Treatment of Mild-to-Moderate Hypertension;The Journal of Clinical Pharmacology;1993-07
5. Nisoldipine: A New Dihydropyridine Calcium-Channel Blocker;The Journal of Clinical Pharmacology;1993-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3